Who invested in Gene+?
Gene+'s investors include GGV Capital, Fortune Venture Capital, Green Pine Capital, Baidu Ventures and BGI Genomics, and 1 more on record.
China · Series D startup
3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 11 months ago
Funding summaryUpdated 26 Oct 2026
$78Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by China Money NetworkSEC filing: $310K sold, first sale Dec 2018
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Gene+'s investors include GGV Capital, Fortune Venture Capital, Green Pine Capital, Baidu Ventures and BGI Genomics, and 1 more on record.
Gene+ has raised $78M across 3 rounds since 2019.
Gene+'s most recent round was a Series D of $42M in Dec 2025.
Its most recent round, $42M in Dec 2025, is also its largest on record.
Gene+'s first round on record, in Jan 2019, was backed by BGI Genomics.
Gene+'s latest named round is a Series D, in Dec 2025.
Gene+ is based in China.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.